Outcomes of midterm circulatory support by left ventricular assist device implantation with descending aortic anastomosis [0.03%]
降主动脉吻合植入左心室辅助装置中期循环支持的结局分析
Kan Nawata,Takashi Nishimura,Shunei Kyo et al.
Kan Nawata et al.
For some patients undergoing left ventricular assist device (LVAD) implantation, the perfusion tube is anastomosed to the descending aorta instead of the currently more prevalently used ascending aorta. Purpose of this study was to assess r...
Influence of three mechanical bileaflet prosthetic valve designs on the three-dimensional flow field inside a simulated aorta [0.03%]
三种机械双叶瓣膜假体对模拟主动脉内三维流场的影响
Toshinosuke Akutsu,Akira Matsumoto
Toshinosuke Akutsu
The current design of the bileaflet valve, the leaflets of which open outside first, differs significantly from the natural valve whose leaflets open center first. This difference generates a completely different flow field in the bileaflet...
In-body optical stimulation formed connective tissue vascular grafts, "biotubes," with many capillaries and elastic fibers [0.03%]
体内光刺激形成连接组织血管移植物"生物管"含许多毛细血管和弹性纤维
Tomonori Oie,Masashi Yamanami,Hatsue Ishibashi-Ueda et al.
Tomonori Oie et al.
The autologous biotube, developed by using in-body tissue architecture technology, is one of the most promising small-diameter vascular grafts in regenerative medicine. The walls of the biotubes obtained by a traditional silicone mold-based...
A new pulse duplicator with a passive fill ventricle for analysis of cardiac dynamics [0.03%]
一种新的脉动重复器具有被动填充心室，用于分析心脏动力学
Yoshimasa Yokoyama,Osamu Kawaguchi,Tadahiko Shinshi et al.
Yoshimasa Yokoyama et al.
A new pulse duplicator was designed for evaluation of the performance of ventricular assist devices through pressure-volume (P-V) diagrams of the native heart. A linear drive system in combination with a pusher-plate mechanism was designed ...
Misplacement of LVAD inflow cannula leads to insufficient output and tissue hypoperfusion [0.03%]
左心室辅助装置流入管置入不当导致心输出量不足和组织灌注不良
Theresa Crumpstone,Tomas D Martin,Jian J Yang et al.
Theresa Crumpstone et al.
A 63-year-old man with a newly placed left ventricular assist device (LVAD) was emergently taken to the operating room for mediastinal exploration secondary to worsened LVAD output, hemodynamic instability, and organ hypoperfusion. Intraope...
Erythrocyte-protective effect of sarpogrelate hydrochloride (Anplag ®), a selective 5-HT2 receptor antagonist: an in vitro study [0.03%]
盐酸沙芬酰胺（安普加）的红细胞保护作用：体外研究
Ken Nakamura,Koji Kawahito
Ken Nakamura
Sarpogrelate hydrochloride (Anplag(®); Mitsubishi Tanabe Pharma Corporation, Osaka, Japan) is a selective S(2)-serotonergic receptor antagonist and is used as an antiplatelet agent. Sarpogrelate has been reported to increase erythrocyte de...
Study of device malfunctions in patients with implantable ventricular assist devices living at home [0.03%]
关于家庭环境中植入式心脏辅助装置患者设备故障的研究
Koichi Kashiwa,Takashi Nishimura,Hitoshi Kubo et al.
Koichi Kashiwa et al.
Clinical introduction of implantable ventricular assist devices (VADs) is expected to encourage VAD therapy for severe heart failure patients in Japan. Since even minor device malfunctions can lead to serious outcomes in these patients, it ...
A novel external counterpulsation system for coronary artery disease and heart failure: pilot studies and initial clinical experiences [0.03%]
一种治疗冠心病和心力衰竭的新型体外反搏系统：初步研究与临床经验
Tsuyoshi Shimizu,Shunei Kyo,Kazuhito Imanaka et al.
Tsuyoshi Shimizu et al.
External counterpulsation (ECP) is a beneficial and noninvasive treatment for coronary artery disease or heart failure; however, it still has a lot of limitations. We used a novel ECP system, Compact CP, the main feature of which is the dou...
Keiko Nishiyama,Makiko Komori,Mitsuharu Kodaka et al.
Keiko Nishiyama et al.
Fires, explosions and electrical accidents in the operating theater are rare events, but are devastating in terms of structural damage to the equipment in theaters and to human lives. While various circumstances lead to these troubles, we c...
The first clinical case in Japan of destination therapy using the Jarvik 2000 left ventricular assist device [0.03%]
日本首例使用Jarvik 2000左心室辅助装置目的地疗法临床病例
Sokichi Kamata,Taichi Sakaguchi,Shigeru Miyagawa et al.
Sokichi Kamata et al.
A 73-year-old female with a history of surgical ventricular restoration for ischemic cardiomyopathy presented with biventricular heart failure symptoms. After a Toyobo paracorporeal left ventricular assist device (LVAD) was implanted as a b...